AC Immune SA | CIK:0001651625 | 3

  • Filed: 3/20/2018
  • Entity registrant name: AC Immune SA (CIK: 0001651625)
  • Generator: EDGARfilings PROfile
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1651625/000095010318003508/0000950103-18-003508-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1651625/000095010318003508/aciu-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001651625
  • Open this page in separate window: Click

    • ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory

    19.
    Commitments and contingencies

      For the Years Ended December 31, 
    in CHF thousands
    		 
    2017
    		  
    2016
    		 
    Within one year
    		  
    9,686
    		   
    9,175
    		 
    Between one and three years
    		  
    2,546
    		   
    1,624
    		 
    Between three and five years  140   - 
    More than five years
    		  -   - 
    Total
    		  
    12,372
    		   
    10,799
    		 

    The Company has research contracts with several external service providers. As of December 31, 2017 external research projects for CHF 9.4 million were committed for 2018. Rental contract for laboratory and offices space at the EPFL Innovation Park in Ecublens/Lausanne can be cancelled within a 6 month notice period. Lease expense in 2017 was CHF 0.5 million. As of December 31, 2017, rental contracts for CHF 0.2 million were committed for 2018.

    The Company has a contractual obligation that requires the payment of royalties to a third party, which is associated with the achievement of program milestones. As of December 31, 2017, the Company’s contractual obligation associated with this agreement was CHF 0.4 million.